We are live on ! Find out more
BA

Bennicas & Associates Portfolio holdings

AUM $173M
1-Year Est. Return 1.55%
This Fund
S&P 500
This Quarter Est. Return
-2.19%
1 Year Est. Return
+1.55%
3 Year Est. Return
+40.28%
5 Year Est. Return
+86.07%
10 Year Est. Return
AUM
$111M
AUM Growth
+$707K
Cap. Flow
+$4.05M
Cap. Flow %
3.67%
Top 10 Hldgs %
36.5%
Holding
89
New
5
Increased
11
Reduced
43
Closed
1

Top Buys

Rank Stock Value
1
K
Kellanova
K
+$1.89M
2
GILD icon
Gilead Sciences
GILD
+$1.69M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$742K
4
OHI icon
Omega Healthcare
OHI
+$241K
5
SNY icon
Sanofi
SNY
+$167K

Sector Composition

Rank Sector Weight
1 Consumer Staples 23.06%
2 Healthcare 12.94%
3 Technology 10.65%
4 Materials 8.46%
5 Industrials 7.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PBR icon
76
Petrobras
PBR
$119B
$227K 0.21%
22,500
-1,300
-5% -$13.9K
PPG icon
77
PPG Industries
PPG
$24.8B
$207K 0.19%
2,182
AU icon
78
AngloGold Ashanti
AU
$39.4B
$190K 0.17%
18,100
-1,000
-5% -$12.1K
NLY icon
79
Annaly Capital Management
NLY
$17.4B
$173K 0.16%
4,342
-825
-16% -$33.6K
HERZ
80
Herzfeld Credit Income Fund
HERZ
$31.3M
$121K 0.11%
2,326
+64
+3% +$3.19K
TEF
81
DELISTED
Telefonica
TEF
$97K 0.09%
13,057
-1,189
-8% -$8.7K
FTR
82
DELISTED
Frontier Communications Corp.
FTR
$97K 0.09%
1,917
-412
-18% -$22.6K
RJI
83
DELISTED
AB Svensk Ekportkredit ELEMENTS Linked to the Rogers International Commodity Index-Total Return
RJI
$84K 0.08%
16,100
-1,000
-6% -$5.05K
HR
84
DELISTED
Healthcare Realty Trust Incorporated
HR
-6,200
Closed -$211K

Similar funds

Bennicas & Associates's Q4 2016 Portfolio in Review

As of Q4 2016, Bennicas & Associates held 89 positions worth $111M, up 0.64% from $110M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Bennicas & Associates deployed $4.05M of net new capital in Q4 2016, opening 5 new positions and adding to 11 existing holdings. Its largest new stake was Kellanova: 27,158 shares worth $1.88M.

By sector, the portfolio is most concentrated in Consumer Staples at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Procter & Gamble, an estimated $157K trimmed.

  • Bennicas & Associates's largest Q4 2016 buy was Kellanova: 27,158 shares worth $1.88M.
  • Bennicas & Associates added most to Sanofi in Q4 2016, an estimated $167K increase.
  • Bennicas & Associates's biggest Q4 2016 reduction was Procter & Gamble, cutting an estimated $157K.
  • Bennicas & Associates fully exited Healthcare Realty Trust Incorporated in Q4 2016, selling an estimated $211K.
  • Bennicas & Associates's ten largest holdings make up 37% of its $111M portfolio in Q4 2016.
  • Bennicas & Associates opened 5 new positions and closed 1 in Q4 2016.
  • Bennicas & Associates's portfolio value rose 0.64% quarter-over-quarter to $111M.

Based on Bennicas & Associates's 13F filing for Q4 2016, filed 19 Jan 2017.